Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Subscribe to our newsletter to be the first to know when new jobs are published!
We firmly believe that embracing diversity and inclusion (D&I) drives innovation, improves scientific and clinical outcomes and contributes to equitable healthcare access for all.
Here at Genentech, that means fostering belonging within our own walls, advancing inclusive research and health equity in our industry at-large and transforming society through partnerships across healthcare, education and within all communities.